Characteristics and first treatment dose of Dutch patients (12-60 years old) receiving prescriptions for asthma and initiating inhaled corticosteroids (ICS) therapy as either extra-fine (EF) ciclesonide or standard-particle (SP)-ICS

Daniela Van Eickles; David Price; Javaria Mona Khalid; Ron Herings; Jetty Overbeek; Julie Von Ziegenweidt; Muzammil Ali; Cristiana Miglio

首页> 外文期刊>World Allergy Organization Journal >Characteristics and first treatment dose of Dutch patients (12-60 years old) receiving prescriptions for asthma and initiating inhaled corticosteroids (ICS) therapy as either extra-fine (EF) ciclesonide or standard-particle (SP)-ICS

【24h】

Characteristics and first treatment dose of Dutch patients (12-60 years old) receiving prescriptions for asthma and initiating inhaled corticosteroids (ICS) therapy as either extra-fine (EF) ciclesonide or standard-particle (SP)-ICS

机译：荷兰患者（12-60岁）接受哮喘处方并以超细（EF）克索奈德或标准颗粒（SP）-ICS形式开始吸入性糖皮质激素（ICS）治疗的特征和首次治疗剂量

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《World Allergy Organization Journal》 |2015年第1期|共页
作者
Daniela Van Eickles; David Price; Javaria Mona Khalid; Ron Herings; Jetty Overbeek; Julie Von Ziegenweidt; Muzammil Ali; Cristiana Miglio;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类变态反应性疾病;
关键词

相似文献

外文文献
中文文献
专利

1. One-year follow up of asthmatic patients newly initiated on treatment with medium- or high-dose inhaled corticosteroid-long-acting beta(2)-agonist in UK primary care settings [J] . Respiratory medicine . 2020,第期

机译：在英国初级保健环境中新发起的哮喘患者新发起的哮喘患者的一年后跟随哮喘患者进行哮喘患者
2. Asthma-Related Outcomes in Patients Initiating Extrafine Ciclesonide or Fine-Particle Inhaled Corticosteroids [J] . Postma Dirkje S., Dekhuijzen Richard, van der Molen Thys, Allergy, Asthma & Immunology Research . 2017,第2期

机译：起始超细Ciclesonide或细颗粒吸入皮质类固醇激素治疗患者的哮喘相关结局
3. A Dose-dependent Effect of the Novel inhaled Corticosteroid Ciclesonide on Airway Responsiveness To Adenosine-5'-Monophosphate in Asthmatic Patients [J] . DAVID A. TAYLOR, MARIANNE W. JENSEN, VARSHA KANABAR American journal of respiratory and critical care medicine . 1999,第1期

机译：新型吸入皮质类固醇Ciclesonide对哮喘患者气道对5'-单磷酸腺苷反应性的剂量依赖性效应
4. Expression of surface markers on peripheral CD4<'+>CD25<'high> T cells in patients with atopic asthma: role of inhaled corticosteroid [C] . Cao Shukun, rnXu Jing, rnShi Lei, Journal of Organ Dysfunction: ISRD 2007 Abstract Book . 2007

机译：特应性哮喘患者外周血CD4'+ CD25 <'high> T细胞表面标志物的表达：吸入糖皮质激素的作用
5. Addition of leukotriene receptor antagonists versus long acting beta agonists to inhaled corticosteroid therapy for asthma treatment in older adults: A retrospective data analysis of effectiveness, safety and cost. [D] . Altawalbeh, Shoroq Mahmoud. 2015

机译：在吸入性糖皮质激素治疗中，将白三烯受体拮抗剂与长效β激动剂相比，用于老年人的哮喘治疗：有效性，安全性和成本的回顾性数据分析。
6. Characteristics and first treatment dose of Dutch patients (12-60 years old) receiving prescriptions for asthma and initiating inhaled corticosteroids (ICS) therapy as either extra-fine (EF) ciclesonide or standard-particle (SP)-ICS [O] . Daniela Van Eickles, David Price, Javaria Mona Khalid, 2015

机译：荷兰患者（12至60岁）接受哮喘处方并以超细（EF）克索奈德或标准颗粒（SP）-ICS形式开始吸入性糖皮质激素（ICS）治疗的特征和首次治疗剂量
7. Characteristics and first treatment dose of Dutch patients (12-60 years old) receiving prescriptions for asthma and initiating inhaled corticosteroids (ICS) therapy as either extra-fine (EF) ciclesonide or standard-particle (SP)-ICS [O] . 2015

机译：荷兰患者（12至60岁）接受哮喘处方并以超细（EF）克索奈德或标准颗粒（SP）-ICS形式开始吸入性糖皮质激素（ICS）治疗的特征和首次治疗剂量

Characteristics and first treatment dose of Dutch patients (12-60 years old) receiving prescriptions for asthma and initiating inhaled corticosteroids (ICS) therapy as either extra-fine (EF) ciclesonide or standard-particle (SP)-ICS

著录项

相似文献

相关主题

期刊订阅